Market Research Logo

Whole Genome Amplification Market: Advent of Lysing Techniques & Primer Technologies to Advocate Preference for Single-cell WGA: Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Whole Genome Amplification Market: Advent of Lysing Techniques & Primer Technologies to Advocate Preference for Single-cell WGA: Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Global Whole Genome Amplification Market

The global Whole genome amplification market report provides analysis and insights on Whole genome amplification kits and consumables. Commercially available Whole genome amplification kits are based on Single cell WGA kits, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and others. Increasing demand for technologically advanced methods in sample preparation, extraction, amplification and testing for nucleic acid and the strategic agreements of manufacturers with leading research institutes to boost research activities in molecular biology field play a vital role for fueling the demand of Whole genome amplification. These Whole genome amplification kits can be used in both clinical diagnostics as well as for research applications. Applications such as agricultural and veterinary animal cell DNA testing, viral and bacterial infectious diseases, drug discovery & development, cancerous diseases, forensic testing, genetically related diseases and paternity testing/HLA typing coupled with rising awareness is predicted to increase usages of whole genome amplification worldwide. This is expected to bolster growth of the Whole genome amplification market over the forecast period.

Global Healthcare Sector Outlook

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Research Methodology

FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Company Description and Whole Genome Amplification Market Research Coverage
3. Whole Genome Amplification Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Global Economic Outlook
4.1. Whole Genome Amplification Market Outlook
5. Market Background
5.1. Technology Evolution
5.2. List of Growth Hacking Manufacturers
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.4. Regulatory Scenario
6. Macroeconomic Assumptions
7. Key Inclusions
7.1. Usage Trend in Whole Genome Amplification Industry
8. North America Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028
8.1. Introduction
8.2. Regional Market Trends
8.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
8.3.1. U.S.
8.3.2. Canada
8.4. Market Size (US$ Mn) Forecast By Country, 2018-2028
8.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017
8.5.1. Single Cell WGA Kit
8.5.2. Complete WGA Kit
8.5.3. WGA Reamplification Kit
8.5.4. WGA and ChIP DNA Kit
8.5.5. DNA Amplification Kit
8.5.6. Others
8.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017
8.7.1. Drug Discovery and Development
8.7.2. Disease Diagnosis
8.7.3. Agriculture and Veterinary Research
8.7.4. Forensics
8.7.5. Others
8.8. Market Size (US$ Mn) Forecast By Application, 2018-2028
8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
8.9.1. Pharmaceutical and Biotechnology Companies
8.9.2. Hospitals and Clinics
8.9.3. Contract Research Organization
8.9.4. Research and Academic Institutes
8.9.5. Others
8.10. Market Size (US$ Mn) Forecast By End User, 2018-2028
8.11. Drivers and Restraints: Impact Analysis
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Product Type
8.12.3. By Application
8.12.4. By End User
8.13. Key Market Participants – Intensity Mapping
8.14. Key Mergers & Acquisitions
9. Western Europe Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028
9.1. Introduction
9.2. Regional Market Trends
9.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
9.3.1. Germany
9.3.2. U.K
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Western Europe
9.4. Market Size (US$ Mn) Forecast By Country, 2018-2028
9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017
9.5.1. Single Cell WGA Kit
9.5.2. Complete WGA Kit
9.5.3. WGA Reamplification Kit
9.5.4. WGA and ChIP DNA Kit
9.5.5. DNA Amplification Kit
9.5.6. Others
9.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
9.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017
9.7.1. Drug Discovery and Development
9.7.2. Disease Diagnosis
9.7.3. Agriculture and Veterinary Research
9.7.4. Forensics
9.7.5. Others
9.8. Market Size (US$ Mn) Forecast By Application, 2018-2028
9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
9.9.1. Pharmaceutical and Biotechnology Companies
9.9.2. Hospitals and Clinics
9.9.3. Contract Research Organization
9.9.4. Research and Academic Institutes
9.9.5. Others
9.10. Market Size (US$ Mn) Forecast By End User, 2018-2028
9.11. Drivers and Restraints: Impact Analysis
9.12. Market Attractiveness Analysis
9.12.1. By Country
9.12.2. By Product Type
9.12.3. By Application
9.12.4. By End User
9.13. Key Market Participants – Intensity Mapping
9.14. Key Mergers & Acquisitions
10. Eastern Europe Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
10.3.1. Russia
10.3.2. Poland
10.3.3. Rest of Eastern Europe
10.4. Market Size (US$ Mn) Forecast By Country, 2018-2028
10.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017
10.5.1. Single Cell WGA Kit
10.5.2. Complete WGA Kit
10.5.3. WGA Reamplification Kit
10.5.4. WGA and ChIP DNA Kit
10.5.5. DNA Amplification Kit
10.5.6. Others
10.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
10.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017
10.7.1. Drug Discovery and Development
10.7.2. Disease Diagnosis
10.7.3. Agriculture and Veterinary Research
10.7.4. Forensics
10.7.5. Others
10.8. Market Size (US$ Mn) Forecast By Application, 2018-2028
10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
10.9.1. Pharmaceutical and Biotechnology Companies
10.9.2. Hospitals and Clinics
10.9.3. Contract Research Organization
10.9.4. Research and Academic Institutes
10.10. Market Size (US$ Mn) Forecast By End User, 2018-2028
10.11. Drivers and Restraints: Impact Analysis
10.12. Market Attractiveness Analysis
10.12.1. By Country
10.12.2. By Product Type
10.12.3. By Application
10.12.4. By End User
10.13. Key Market Participants – Intensity Mapping
10.14. Key Mergers & Acquisitions
11. Latin America Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Size (US$ Mn) Forecast By Country, 2018-2028
11.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017
11.5.1. Single Cell WGA Kit
11.5.2. Complete WGA Kit
11.5.3. WGA Reamplification Kit
11.5.4. WGA and ChIP DNA Kit
11.5.5. DNA Amplification Kit
11.5.6. Others
11.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
11.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017
11.7.1. Drug Discovery and Development
11.7.2. Disease Diagnosis
11.7.3. Agriculture and Veterinary Research
11.7.4. Forensics
11.7.5. Others
11.8. Market Size (US$ Mn) Forecast By Application, 2018-2028
11.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
11.9.1. Pharmaceutical and Biotechnology Companies
11.9.2. Hospitals and Clinics
11.9.3. Contract Research Organization
11.9.4. Research and Academic Institutes
11.9.5. Others
11.10. Market Size (US$ Mn) Forecast By End User, 2018-2028
11.11. Drivers and Restraints: Impact Analysis
11.12. Market Attractiveness Analysis
11.12.1. By Country
11.12.2. By Product Type
11.12.3. By Application
11.12.4. By End User
11.13. Key Market Participants – Intensity Mapping
11.14. Key Mergers & Acquisitions
12. Asia Pacific Excluding Japan Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028
12.1. Introduction
12.2. Regional Market Trends
12.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
12.3.1. China
12.3.2. India
12.3.3. Australia and New Zealand
12.3.4. ASEAN
12.3.5. Rest of APECJ
12.4. Market Size (US$ Mn) Forecast By Country, 2018-2028
12.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017
12.5.1. Single Cell WGA Kit
12.5.2. Complete WGA Kit
12.5.3. WGA Reamplification Kit
12.5.4. WGA and ChIP DNA Kit
12.5.5. DNA Amplification Kit
12.5.6. Others
12.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
12.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017
12.7.1. Drug Discovery and Development
12.7.2. Disease Diagnosis
12.7.3. Agriculture and Veterinary Research
12.7.4. Forensics
12.7.5. Others
12.8. Market Size (US$ Mn) Forecast By Application, 2018-2028
12.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
12.9.1. Pharmaceutical and Biotechnology Companies
12.9.2. Hospitals and Clinics
12.9.3. Contract Research Organization
12.9.4. Research and Academic Institutes
12.9.5. Others
12.10. Market Size (US$ Mn) Forecast By End User, 2018-2028
12.11. Drivers and Restraints: Impact Analysis
12.12. Market Attractiveness Analysis
12.12.1. By Country
12.12.2. By Product Type
12.12.3. By Application
12.12.4. By End User
12.13. Key Market Participants – Intensity Mapping
12.14. Key Mergers & Acquisitions
13. Japan Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028
13.1. Introduction
13.2. Regional Market Trends
13.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017
13.3.1. Single Cell WGA Kit
13.3.2. Complete WGA Kit
13.3.3. WGA Reamplification Kit
13.3.4. WGA and ChIP DNA Kit
13.3.5. DNA Amplification Kit
13.3.6. Others
13.4. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
13.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017
13.5.1. Drug Discovery and Development
13.5.2. Disease Diagnosis
13.5.3. Agriculture and Veterinary Research
13.5.4. Forensics
13.5.5. Others
13.6. Market Size (US$ Mn) Forecast By Application, 2018-2028
13.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
13.7.1. Pharmaceutical and Biotechnology Companies
13.7.2. Hospitals and Clinics
13.7.3. Contract Research Organization
13.7.4. Research and Academic Institutes
13.7.5. Others
13.8. Market Size (US$ Mn) Forecast By End User, 2018-2028
13.9. Drivers and Restraints: Impact Analysis
13.10. Market Attractiveness Analysis
13.10.1. By Product Type
13.10.2. By Application
13.10.3. By End User
13.11. Key Market Participants – Intensity Mapping
13.12. Key Mergers & Acquisitions
14. Middle East and Africa Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028
14.1. Introduction
14.2. Regional Market Trends
14.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of Middle East and Africa
14.4. Market Size (US$ Mn) Forecast By Country, 2018-2028
14.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017
14.5.1. Single Cell WGA Kit
14.5.2. Complete WGA Kit
14.5.3. WGA Reamplification Kit
14.5.4. WGA and ChIP DNA Kit
14.5.5. DNA Amplification Kit
14.5.6. Others
14.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
14.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017
14.7.1. Drug Discovery and Development
14.7.2. Disease Diagnosis
14.7.3. Agriculture and Veterinary Research
14.7.4. Forensics
14.7.5. Others
14.8. Market Size (US$ Mn) Forecast By Application, 2018-2028
14.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
14.9.1. Pharmaceutical and Biotechnology Companies
14.9.2. Hospitals and Clinics
14.9.3. Contract Research Organization
14.9.4. Research and Academic Institutes
14.9.5. Others
14.10. Market Size (US$ Mn) Forecast By End User, 2018-2028
14.11. Drivers and Restraints: Impact Analysis
14.12. Market Attractiveness Analysis
14.12.1. By Country
14.12.2. By Product Type
14.12.3. By Application
14.12.4. By End User
14.13. Key Market Participants – Intensity Mapping
14.14. Key Mergers & Acquisitions
15. Forecast Factors: Relevance and Impact
16. Forecast Assumptions
17. Market Structure Analysis
17.1.Market Structure by Tier of Companies
17.2.Market Share Analysis (2017) for Top 10 Players, By Region
17.3.Production Capacity Analysis, By Key Players
17.4.Pricing Analysis By Key Players, By Region
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Profitability and Gross Margin Analysis By Competition
18.4. Company Deep Dive
18.4.1. Sigma-Aldrich Co. LLC.
18.4.1.1. Overview
18.4.1.2. Product and Application Portfolio
18.4.1.3. Production Footprint
18.4.1.4. Sales Footprint
18.4.1.5. Channel Footprint
18.4.1.6. Strategy
18.4.1.6.1. Marketing Strategy
18.4.1.6.2. Product Strategy
18.4.1.6.3. Channel Strategy
18.4.2. QIAGEN N.V.
18.4.2.1. Overview
18.4.2.2. Product and Application Portfolio
18.4.2.3. Production Footprint
18.4.2.4. Sales Footprint
18.4.2.5. Channel Footprint
18.4.2.6. Strategy
18.4.2.6.1. Marketing Strategy
18.4.2.6.2. Product Strategy
18.4.2.6.3. Channel Strategy
18.4.3. Thermo Fisher Scientific Inc.
18.4.3.1. Overview
18.4.3.2. Product and Application Portfolio
18.4.3.3. Production Footprint
18.4.3.4. Sales Footprint
18.4.3.5. Channel Footprint
18.4.3.6. Strategy
18.4.3.6.1. Marketing Strategy
18.4.3.6.2. Product Strategy
18.4.3.6.3. Channel Strategy
18.4.4. Illumina, Inc.
18.4.4.1. Overview
18.4.4.2. Product and Application Portfolio
18.4.4.3. Production Footprint
18.4.4.4. Sales Footprint
18.4.4.5. Channel Footprint
18.4.4.6. Strategy
18.4.4.6.1. Marketing Strategy
18.4.4.6.2. Product Strategy
18.4.4.6.3. Channel Strategy
18.4.5. SYGNIS AG
18.4.5.1. Overview
18.4.5.2. Product and Application Portfolio
18.4.5.3. Production Footprint
18.4.5.4. Sales Footprint
18.4.5.5. Channel Footprint
18.4.5.6. Strategy
18.4.5.6.1. Marketing Strategy
18.4.5.6.2. Product Strategy
18.4.5.6.3. Channel Strategy
18.4.6. Active Motif, Inc.
18.4.6. Overview
18.4.6.2. Product and Application Portfolio
18.4.6.3. Production Footprint
18.4.6.4. Sales Footprint
18.4.6.5. Channel Footprint
18.4.6.6. Strategy
18.4.6.6.1. Marketing Strategy
18.4.6.6.2. Product Strategy
18.4.6.6.3. Channel Strategy
18.4.7. LGC Limited
18.4.7.1. Overview
18.4.7.2. Product and Application Portfolio
18.4.7.3. Production Footprint
18.4.7.4. Sales Footprint
18.4.7.5. Channel Footprint
18.4.7.6. Strategy
18.4.7.6.1. Marketing Strategy
18.4.7.6.2. Product Strategy
18.4.7.6.3. Channel Strategy
18.4.8. Yikon Genomics
18.4.8.1. Overview
18.4.8.2. Product and Application Portfolio
18.4.8.3. Production Footprint
18.4.8.4. Sales Footprint
18.4.8.5. Channel Footprint
18.4.8.6. Strategy
18.4.8.6.1. Marketing Strategy
18.4.8.6.2. Product Strategy
18.4.8.6.3. Channel Strategy
18.4.9. General Electric Company
18.4.9.1. Overview
18.4.9.2. Product and Application Portfolio
18.4.9.3. Production Footprint
18.4.9.4. Sales Footprint
18.4.9.5. Channel Footprint
18.4.9.6. Strategy
18.4.9.6.1. Marketing Strategy
18.4.9.6.2. Product Strategy
18.4.9.6.3. Channel Strategy
19. Global Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028 By Region
19.1. Introduction / Key Findings
19.2. Historical Market Size (US$ Mn) Analysis By Region
19.2.1. North America
19.2.2. Western Europe
19.2.3. Eastern Europe
19.2.4. Latin America
19.2.5. Asia Pacific Excluding Japan
19.2.6. Japan
19.2.7. Middle East and Africa
19.3. Market Size (US$ Mn) Forecast By Region
19.4. Market Attractiveness Analysis By Region
20. Global Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028, By Product Type
20.1. Introduction/Key Finding
20.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017
20.2.1. Single Cell WGA Kit
20.2.2. Complete WGA Kit
20.2.3. WGA Reamplification Kit
20.2.4. WGA and ChIP DNA Kit
20.2.5. DNA Amplification Kit
20.2.6. Others
20.3. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
20.4. Market Attractiveness Analysis By Product Type
21. Global Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028, By Application
21.1.Introduction/Key Finding
21.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017
21.2.1. Drug Discovery and Development
21.2.2. Disease Diagnosis
21.2.3. Agriculture and Veterinary Research
21.2.4. Forensics
21.2.5. Others
21.3.Market Size (US$ Mn) Forecast By Application, 2018-2028
21.4.Market Attractiveness Analysis By Application
22. Global Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028, By End User
22.1.Introduction/Key Finding
22.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
22.2.1. Pharmaceutical and Biotechnology Companies
22.2.2. Hospitals and Clinics
22.2.3. Contract Research Organization
22.2.4. Research and Academic Institutes
22.2.5. Others
22.3.Market Size (US$ Mn) Forecast By End User, 2018-2028
22.4.Market Attractiveness Analysis By End User
23. Global Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028
23.1.Market Value Share Analysis By All Segment
23.2.Y-o-Y Growth Analysis By All Segment
23.3.Absolute $ Opportunity
24. Assumptions and Acronyms Used
25 . Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report